MEDIATOR RELEASE IN CEREBROSPINAL-FLUID OF HUMAN IMMUNODEFICIENCY VIRUS-POSITIVE PATIENTS WITH CENTRAL-NERVOUS-SYSTEM INVOLVEMENT

被引:18
作者
FROLDI, M
CASTAGNA, A
PARMA, M
PIONA, A
TEDESCHI, A
MIADONNA, A
LORINI, M
ORAZIO, EN
LAZZARIN, A
机构
[1] UNIV MILAN,NEUROL CLIN,I-20122 MILAN,ITALY
[2] UNIV MILAN,IST MED INTERNA MALATTIE INFETT & IMMUNOPATOL,I-20122 MILAN,ITALY
关键词
HUMAN IMMUNODEFICIENCY VIRUS; CEREBROSPINAL FLUID; LEUKOTRIENE-B(4);
D O I
10.1016/0165-5728(92)90100-Y
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In this study we evaluated the release of some mediators of inflammatory reactions such as histamine (H), leukotriene B4 (LTB4), leukotriene C4 (LTC4) and prostaglandin D2 (PGD2) in the cerebrospinal fluid (CSF) of 15 patients with acquired immunodeficiency syndrome (AIDS), eight with opportunistic infections of the central nervous system (CNS) and seven without HIV-related neurological pathology, and of 25 HIV-negative control subjects with other neurological diseases. The cerebrospinal LTB4 level was increased in all the AIDS patients (mean 348 pg/ml); the control group revealed normal levels of LTB4 in the CSF (mean 63.2 pg/ml). The PGD2 level in the HIV-positive (mean 264 pg/ml) patients was higher than of the control subjects (mean 50 pg/ml), while low LTC4 levels were found both in the HIV-positive and control groups. We did not find any significant concentration of H in the CSF of either the HIV-positive or the control subjects. These findings may be due to the presence of chronic HIV infection or to the opportunistic infections of the CNS that so often occur in the latest stages of the disease.
引用
收藏
页码:155 / 161
页数:7
相关论文
共 36 条
[1]  
BAENA RRY, 1987, ADV PROSTAGLANDINS T, V17, P938
[2]  
BERGER JR, 1989, ACTA NEUROL SCA S116, V77, P40
[3]   CEREBROSPINAL-FLUID BETA-2 MICROGLOBULIN IN PATIENTS INFECTED WITH HUMAN IMMUNODEFICIENCY VIRUS [J].
BREW, BJ ;
BHALLA, RB ;
FLEISHER, M ;
PAUL, M ;
KHAN, A ;
SCHWARTZ, MK ;
PRICE, RW .
NEUROLOGY, 1989, 39 (06) :830-834
[4]   CEREBROSPINAL-FLUID NEOPTERIN IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
BREW, BJ ;
BHALLA, RB ;
PAUL, M ;
GALLARDO, H ;
MCARTHUR, JC ;
SCHWARTZ, MK ;
PRICE, RW .
ANNALS OF NEUROLOGY, 1990, 28 (04) :556-560
[6]   THE INVOLVEMENT OF THE CEREBRAL-CORTEX IN HUMAN-IMMUNODEFICIENCY-VIRUS ENCEPHALOPATHY - A MORPHOLOGICAL AND IMMUNOHISTOCHEMICAL STUDY [J].
CIARDI, A ;
SINCLAIR, E ;
SCARAVILLI, F ;
HARCOURTWEBSTER, NJ ;
LUCAS, S .
ACTA NEUROPATHOLOGICA, 1990, 81 (01) :51-59
[7]   HIV-1 COAT PROTEIN NEUROTOXICITY PREVENTED BY CALCIUM-CHANNEL ANTAGONISTS [J].
DREYER, EB ;
KAISER, PK ;
OFFERMANN, JT ;
LIPTON, SA .
SCIENCE, 1990, 248 (4953) :364-367
[8]   CSF AND SERUM BETA-2-MICROGLOBULIN IN HIV INFECTION RELATED TO NEUROLOGICAL DYSFUNCTION [J].
ELOVAARA, I ;
IIVANAINEN, M ;
POUTIAINEN, E ;
VALLE, SL ;
WEBER, T ;
SUNI, J ;
LAHDEVIRTA, J .
ACTA NEUROLOGICA SCANDINAVICA, 1989, 79 (02) :81-87
[9]   NEOPTERIN CONCENTRATIONS IN CEREBROSPINAL-FLUID AND SERUM OF INDIVIDUALS INFECTED WITH HIV-1 [J].
FUCHS, D ;
CHIODI, F ;
ALBERT, J ;
ASJO, B ;
HAGBERG, L ;
HAUSEN, A ;
NORKRANS, G ;
REIBNEGGER, G ;
WERNER, ER ;
WACHTER, H .
AIDS, 1989, 3 (05) :285-288
[10]   NEOPTERIN AS A MARKER FOR ACTIVATED CELL-MEDIATED-IMMUNITY - APPLICATION IN HIV INFECTION [J].
FUCHS, D ;
HAUSEN, A ;
REIBNEGGER, G ;
WERNER, ER ;
DIERICH, MP ;
WACHTER, H .
IMMUNOLOGY TODAY, 1988, 9 (05) :150-155